YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
YIHCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,532,490 | $3,441,698 | $3,338,122 | $3,064,243 |
| - Cash | $1,403,777 | $1,674,413 | $923,543 | $1,131,121 |
| + Debt | $2,234,835 | $2,609,328 | $3,821,835 | $3,193,502 |
| Enterprise Value | $4,363,548 | $4,376,613 | $6,236,414 | $5,126,624 |
| Revenue | $3,723,783 | $6,294,585 | $3,744,952 | $913,788 |
| % Growth | -40.8% | 68.1% | 309.8% | – |
| Gross Profit | $2,794,058 | $4,985,764 | $2,846,074 | $483,699 |
| % Margin | 75% | 79.2% | 76% | 52.9% |
| EBITDA | $1,070,422 | $2,745,443 | $691,483 | -$206,554 |
| % Margin | 28.7% | 43.6% | 18.5% | -22.6% |
| Net Income | $482,712 | $1,992,624 | $76,603 | -$587,649 |
| % Margin | 13% | 31.7% | 2% | -64.3% |
| EPS Diluted | 0.55 | 2.26 | 0.087 | -0.67 |
| % Growth | -75.7% | 2,494.7% | 113% | – |
| Operating Cash Flow | $89,418 | $1,673,212 | $1,699,909 | -$662,510 |
| Capital Expenditures | -$1,182,103 | -$595,078 | -$570,070 | -$356,285 |
| Free Cash Flow | -$1,092,685 | $1,078,134 | $1,129,839 | -$1,018,795 |